Check out our most popular compounded medications! Get Started
Description: Quetiapine Fumarate 10 mg/ml Gastric Tube Liquid is a specially compounded medication intended for administration through a gastric tube. This formulation provides a precise 10 mg/ml concentration of Quetiapine Fumarate, an antipsychotic medication used to treat a range of psychiatric conditions. It is particularly beneficial for patients who are unable to swallow oral medications. This liquid formulation is commonly utilized in hospital settings and for patients with swallowing difficulties. Quetiapine is indicated for the treatment of schizophrenia, bipolar disorder, and as an adjunct therapy for major depressive disorder.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Quetiapine Fumarate 10 mg/ml Gastric Tube Liquid is a specialized formulation designed for patients who require the antipsychotic medication Quetiapine but are unable to take it orally due to swallowing difficulties or other impediments. This liquid formulation is intended for administration through a gastric tube, which is a common necessity in hospital settings or for patients with conditions that impair their ability to swallow tablets or capsules. The concentration of 10 mg/ml allows for precise dosing, which is critical in managing the symptoms of various psychiatric disorders.
Quetiapine is an atypical antipsychotic that works by modulating the activity of neurotransmitters in the brain, particularly serotonin and dopamine. This action helps to balance the chemical disturbances in patients with schizophrenia, bipolar disorder, and major depressive disorder. In schizophrenia, Quetiapine can reduce hallucinations, improve thought processes, and help with social interactions.
The liquid formulation is particularly beneficial for patients with conditions that make swallowing solid dosage forms challenging, such as those with esophageal strictures, neurological disorders like Parkinson's disease, or patients who are intubated or have had a stroke. The use of a gastric tube ensures that the medication is delivered directly to the stomach, bypassing the need for oral ingestion, and reducing the risk of aspiration which can occur in patients with compromised swallowing reflexes.
It is important for prescribers to consider the specific needs of their patients when choosing this formulation. The liquid form allows for flexible dosing, which can be adjusted according to the patient's response and tolerance to the medication. Additionally, the prescriber should monitor the patient for any potential side effects, such as sedation, orthostatic hypotension, or extrapyramidal symptoms, and adjust the dose accordingly. Regular monitoring of the patient's condition and response to therapy is essential for optimal treatment outcomes.
For patients and healthcare providers interested in using Quetiapine Fumarate 10 mg/ml Gastric Tube Liquid, it is crucial to understand the proper administration techniques for gastric tubes to ensure the medication's efficacy and the patient's safety. Our team at Bayview Pharmacy is available to provide guidance on the preparation and administration of this formulation, as well as to answer any questions regarding its use and the conditions it treats. If you have any questions or require further information, please do not hesitate to reach out to us.
Quetiapine fumarate is an atypical antipsychotic medication used to treat various psychiatric conditions such as schizophrenia, bipolar disorder, and major depressive disorder. When formulated as a 10 mg/ml gastric tube liquid, it is particularly useful for patients who have difficulty swallowing or require enteral feeding. However, it is important to consider potential drug interactions when administering quetiapine in this manner.
Quetiapine is metabolized primarily by the cytochrome P450 3A4 (CYP3A4) enzyme. Therefore, drugs that are strong inducers or inhibitors of this enzyme can significantly affect the plasma concentration of quetiapine. Strong CYP3A4 inhibitors, such as ketoconazole, itraconazole, and ritonavir, can increase quetiapine exposure, potentially leading to enhanced effects and an increased risk of adverse reactions, including QT prolongation. Conversely, strong CYP3A4 inducers, such as phenytoin, carbamazepine, and rifampin, can decrease quetiapine plasma levels, reducing its efficacy.
Quetiapine has the potential to cause orthostatic hypotension, particularly during the initial dose-titration period. Caution is advised when quetiapine is co-administered with other drugs known to cause orthostatic hypotension or central nervous system (CNS) depression, such as benzodiazepines, opioids, and antihypertensive medications. The risk of hypotension and CNS depression may be compounded, necessitating close monitoring of blood pressure and level of sedation.
Additionally, quetiapine can have additive effects on the prolongation of the QT interval, a measure of cardiac rhythm. Care should be taken when it is used concurrently with other medications known to prolong the QT interval, such as certain antiarrhythmic drugs, macrolide antibiotics, and some antipsychotics. Electrocardiogram (ECG) monitoring may be warranted with concurrent use of these medications.
Quetiapine may also interact with drugs that have anticholinergic properties, as it possesses anticholinergic activity itself. The use of quetiapine with other anticholinergics can increase the risk of urinary retention, constipation, and heat intolerance, especially in the elderly.
It is important to note that the absorption of quetiapine is not significantly affected by food, so the liquid formulation can be administered without regard to meals. However, the concurrent use of quetiapine with alcohol is not recommended due to the potential for increased CNS depressant effects.
Lastly, caution should be exercised when quetiapine is prescribed with medications known to affect electrolyte balance or those that are associated with an increased risk of seizures. Electrolyte imbalances (such as hypokalemia or hypomagnesemia) can increase the risk of QT prolongation, and seizure threshold may be lowered with the concurrent use of certain medications such as bupropion or tramadol.
Given the complexity of drug interactions with quetiapine, it is crucial for prescribers to thoroughly review a patient's medication regimen before initiating treatment with quetiapine fumarate gastric tube liquid. Pharmacists can provide valuable assistance in identifying potential drug interactions and recommending appropriate monitoring strategies. If you have any questions or require further information regarding drug interactions with quetiapine fumarate, please reach out to us at Bayview Pharmacy.
The Quetiapine Fumarate 10 mg/ml Gastric Tube Liquid is a specially compounded medication designed for administration through a gastric tube. This formulation is particularly beneficial for patients who are unable to take oral medications due to various reasons such as dysphagia (difficulty swallowing), unconsciousness, or severe psychiatric conditions that impair the ability to swallow tablets or capsules. The liquid form ensures that the medication can be delivered directly to the stomach, providing a reliable and controlled method of administration.
Quetiapine fumarate, the active ingredient in this formulation, is an atypical antipsychotic medication. It works by modulating the activity of various neurotransmitters in the brain, including serotonin and dopamine. These neurotransmitters are known to be involved in the pathophysiology of several psychiatric disorders. By altering their activity, quetiapine fumarate can help to stabilize mood, reduce hallucinations and delusions, and improve thought processes.
This medication is commonly used in the treatment of several disease states, including schizophrenia, bipolar disorder, and major depressive disorder as part of a combination therapy. In schizophrenia, quetiapine helps to manage symptoms such as disorganized thinking, social withdrawal, and hallucinations. When used for major depressive disorder, it is typically added to an antidepressant regimen to enhance therapeutic effects.
The compounding of quetiapine into a 10 mg/ml gastric tube liquid requires careful consideration of the drug's stability, solubility, and compatibility with enteral feeding systems. The concentration of 10 mg/ml allows for easy dose adjustments and precise measurement of the medication to meet the individual needs of each patient.
Regular follow-up and communication with the healthcare team are crucial to ensure optimal treatment outcomes. If you have any questions about this formulation or its use in specific disease states, please do not hesitate to reach out to us at Bayview Pharmacy. Our knowledgeable team of compounding pharmacists is here to provide support and guidance.
Quetiapine Fumarate 10 mg/ml Gastric Tube Liquid is a specially formulated medication designed for administration through a gastric tube. This liquid formulation is used to deliver the antipsychotic drug Quetiapine Fumarate to patients who are unable to swallow pills or tablets, such as those with swallowing difficulties or in a hospital setting.
The medication is administered directly into the stomach through a gastric tube, which is a tube inserted through the nose or mouth that reaches into the stomach. This allows for safe and accurate dosing of the medication for patients who cannot take it orally.
Quetiapine Fumarate Gastric Tube Liquid is primarily intended for patients who have difficulty swallowing or cannot swallow solid forms of medication. It is important to consult a healthcare professional to determine if this formulation is appropriate for an individual's specific medical condition and needs.
As the medication is administered directly into the stomach, it bypasses the need to take it orally with food. However, it is advisable to follow specific instructions provided by a healthcare provider regarding the administration of this medication with respect to meals.
Quetiapine Fumarate Gastric Tube Liquid should be stored at room temperature, away from light and moisture. Always refer to the medication's label for specific storage instructions, and consult a pharmacist if you are unsure.
The liquid medication should come with dosing instructions and possibly specialized measuring tools such as a syringe or measuring cup. Always use these tools and follow the prescribed dosage instructions carefully to ensure the correct amount of medication is administered.
If a dose is missed, administer it as soon as you remember, unless it is close to the time for the next dose. In that case, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up. Always consult with a healthcare provider if you have any concerns.
Generally, it's not recommended to mix medication with other liquids unless instructed by a healthcare professional. Some mixtures can cause changes in the medication's effectiveness or increase the risk of side effects.
The side effects of the liquid form are similar to those of the tablet form and can include drowsiness, dizziness, and dry mouth. It's important to consult a healthcare provider for a complete list of potential side effects and to discuss any symptoms that occur.
Individuals who are allergic to quetiapine or any component of the formulation should not use this medication. Additionally, certain medical conditions may contraindicate its use. A healthcare provider can provide information on whether this medication is safe for an individual based on their medical history and current health conditions.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
